Cardiovascular & Hematological Disorders-Drug Targets
Title:Preface
Volume: 24 Issue: 1
Author(s): Pietro Scicchitano
Affiliation:
Export Options
About this article
Cite this article as:
Scicchitano Pietro, Preface, Cardiovascular & Hematological Disorders-Drug Targets 2024; 24 (1) . https://dx.doi.org/10.2174/1871529X2401240708142101
DOI https://dx.doi.org/10.2174/1871529X2401240708142101 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Call for Papers in Thematic Issues
Effective Lowering pf Lipoprotein (a) – A new Frontier in Cardiovascular Risk Reduction
Elevated lipoprotein(a) (Lp[a]) is a genetically determined cardiovascular risk factor, causally linked to both atherosclerotic coronary artery disease and aortic valve stenosis. Elevated Lp(a) is widely prevalent, and several cardiovascular societies now recommend performing Lp(a) screening at least once in all adults. While, there are currently no approved drugs aimed ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements